Clariant is well on track
Clariant , a world leader in Specialty Chemicals, provided an update on Capital Markets Day on June 28, 2013, and on its strategy to reach the mid-term targets in 2015
Of course the focus is no longer on the businesses to be disposed (Textile Effects and Leather Divisions), awaiting shortly the finalisation process, but on recent developments in Crop Care, Personal Care and Oil and Mining services.
In order to create further value, investments into R&D and innovation has been constantly increased, lieading to some recent successes in the product pipeline, such as its crop care adjuvant Synergen® or its de-emulsifier Phasetreat®, an award winning product in oil services. These investments into R&D over the past5 two years become now visible. The innovation pipeline is constantly growing and currently has a sales potential of more than one billion CHF by 2017, declared CEO Hariolf Kottmann. Combined with a focus on customers and markets, Clariant will be in an even better position to exploit the potential of its R&D pipeline.
For the ongoing year, Clariant will focus on accelerating top line growth, finalising the portfolio measures (disposals) as well as maintaining a high cost discipline. Kottmann is convinced that Clariant has a sound financial basis for executing the profitable growth strategy that will lead to an increase in local currency sales and higher EBITDA margin in 2013. Beyond 2014, the company strives for continuity, reflected in an above GDP top line growth and sustained high profitability.